Combining N-of-1 Trials to Assess Fibromyalgia Treatments - Related Studies

Combining N-of-1 Trials to Assess Fibromyalgia Treatments

This study has been completed.

Study NCT00000428. Last updated on March 5, 2008. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Fibromyalgia

2	Additional conditions recognized in this trial
		Myofascial Pain Syndromes

3	More general conditions related to this trial
		Muscular Diseases
		Musculoskeletal Diseases
		Nervous System Diseases
		Neuromuscular Diseases
		Rheumatic Diseases

4	Interventions listed in this trial
		Amitriptyline
		Amitriptyline plus Fluoxitine

5	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic Uptake Inhibitors
		Analgesics
		Analgesics, Non-Narcotic
		Antidepressive Agents
		Antidepressive Agents, Tricyclic
		Central Nervous System Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)